{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T12:07:16Z","timestamp":1792670836252,"version":"4.5.0"},"reference-count":14,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.3201\/eid2202.150369","type":"journal-article","created":{"date-parts":[[2016,1,12]],"date-time":"2016-01-12T12:45:35Z","timestamp":1452602735000},"page":"309-311","source":"Crossref","is-referenced-by-count":98,"title":["Effectiveness of Meningococcal B Vaccine against Endemic Hypervirulent<i>Neisseria<\/i><i>meningitidis<\/i>W Strain, England"],"prefix":"10.3201","volume":"22","author":[{"given":"Shamez N.","family":"Ladhani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzia Monica","family":"Giuliani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Biolchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariagrazia","family":"Pizza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazim","family":"Beebeejaun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay","family":"Lucidarme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie","family":"Findlow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary E.","family":"Ramsay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ray","family":"Borrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1822","reference":[{"key":"key-10.3201\/eid2202.150369-201601141040-R1","doi-asserted-by":"publisher","first-page":"3710","DOI":"10.1016\/j.vaccine.2012.03.011","article-title":"Invasive meningococcal disease in England and Wales: implications for the introduction of new vaccines.","volume":"30","author":"Ladhani","year":"2012","journal-title":"Vaccine"},{"key":"key-10.3201\/eid2202.150369-201601141040-R2","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/S0140-6736(02)07716-4","article-title":"W135 meningococcal disease in England and Wales associated with Hajj 2000 and 2001.","volume":"359","author":"Hahn\u00e9","year":"2002","journal-title":"Lancet"},{"key":"key-10.3201\/eid2202.150369-201601141040-R3","first-page":"578","article-title":"Increase in endemic Neisseria meningitidis capsular group W sequence type 11 complex associated with severe invasive disease in England and Wales.","volume":"\u2022\u2022\u2022","author":"Ladhani","year":"2014","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2202.150369-201601141040-R4","doi-asserted-by":"publisher","first-page":"339","DOI":"10.3201\/eid2102.140746","article-title":"Neisseria meningitidis ST-11 clonal complex, Chile 2012.","volume":"21","author":"Araya","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid2202.150369-201601141040-R5","first-page":"17","article-title":"W135 invasive meningococcal infections imported from Sub-Saharan Africa to France, January to April 2012.","volume":"\u2022\u2022\u2022","author":"Parent du Ch\u00e2telet","year":"2012","journal-title":"Euro Surveill"},{"key":"key-10.3201\/eid2202.150369-201601141040-R6","unstructured":"Department of Health. Pneumococcal. In: Salisbury D, Ramsay M, Noakes K, editors. Immunisation against infectious disease. Norwick (UK): The Stationery Office; 2006 [updated 2011]. p. 295\u2013313"},{"key":"key-10.3201\/eid2202.150369-201601141040-R7","doi-asserted-by":"publisher","first-page":"g2415","DOI":"10.1136\/bmj.g2415","article-title":"Introducing a new group B meningococcus vaccine.","volume":"348","author":"Isaacs","year":"2014","journal-title":"BMJ"},{"key":"key-10.3201\/eid2202.150369-201601141040-R8","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1001\/jama.2012.85","article-title":"Immunogenicity and tolerability of recombinant serogroup B meningococcal vaccine administered with or without routine infant vaccinations according to different immunization schedules: a randomized controlled trial.","volume":"307","author":"Gossger","year":"2012","journal-title":"JAMA"},{"key":"key-10.3201\/eid2202.150369-201601141040-R9","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/S1473-3099(13)70006-9","article-title":"Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessment.","volume":"13","author":"Vogel","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"key-10.3201\/eid2202.150369-201601141040-R10","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1084\/jem.20020407","article-title":"NadA, a novel vaccine candidate of Neisseria meningitidis.","volume":"195","author":"Comanducci","year":"2002","journal-title":"J Exp Med"},{"key":"key-10.3201\/eid2202.150369-201601141040-R11","doi-asserted-by":"publisher","first-page":"B20","DOI":"10.1016\/j.vaccine.2009.04.067","article-title":"Meningococcal C conjugate vaccine: the experience in England and Wales.","volume":"27","author":"Campbell","year":"2009","journal-title":"Vaccine"},{"key":"key-10.3201\/eid2202.150369-201601141040-R12","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/S1473-3099(10)70251-6","article-title":"Meningococcal carriage by age: a systematic review and meta-analysis.","volume":"10","author":"Christensen","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"key-10.3201\/eid2202.150369-201601141040-R13","doi-asserted-by":"publisher","first-page":"4968","DOI":"10.1016\/j.vaccine.2013.08.006","article-title":"Bactericidal antibody against a representative epidemiological meningococcal serogroup B panel confirms that MATS underestimates 4CMenB vaccine strain coverage.","volume":"31","author":"Frosi","year":"2013","journal-title":"Vaccine"},{"key":"key-10.3201\/eid2202.150369-201601141040-R14","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1016\/S0140-6736(14)60842-4","article-title":"Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: an observer-blind, phase 3 randomised clinical trial.","volume":"384","author":"Read","year":"2014","journal-title":"Lancet"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"link":[{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/22\/2\/15-0369_article","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T23:24:30Z","timestamp":1732922670000},"score":1,"resource":{"primary":{"URL":"http:\/\/wwwnc.cdc.gov\/eid\/article\/22\/2\/15-0369_article.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":14,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"URL":"https:\/\/doi.org\/10.3201\/eid2202.150369","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"value":"1080-6040","type":"print"},{"value":"1080-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2]]}}}